EUVIMEDEUVIMED entdecken
Open Access

Extracellular vesicles from steatotic hepatocytes promote endothelial dysfunction and atherogenesis via miR-30b-5p/ELOVL5 axis

Marie Rhee, Joonyub Lee, Cheol Woon Jung, Jinsung Yang, Won Gun Choi, Young-Hye You, Heon-Seok Park, Eun Young Lee, Eun Kyung Lee, Sung Won Kwon, Young-Bum Kim, Seung-Hwan Lee

Molecular Therapy · 2026-09 · 34 (9) · 5382-5398

DOI: 10.1016/j.ymthe.2026.06.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-09. Verfasst von Marie Rhee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of…. Hauptthemen laut MEDLINE: MicroRNAs, Atherosclerosis, Hepatocytes, Fatty Acid Elongases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as an independent risk factor for cardiovascular disease (CVD), yet the underlying molecular pathways mediating liver-to-vasculature communication remain largely unidentified. Here, we show that extracellular vesicles (EVs) derived from hepatocytes contribute to endothelial dysfunction and atherogenesis. Treatment with EVs derived from palmitic acid (PA)-treated hepatocytes induced inflammation and endothelial dysfunction in human endothelial cells. miR-30b-5p was identified as a candidate cargo, and its elevation was confirmed by qPCR in EVs from PA-treated hepatocytes and Western-diet-induced steatotic livers. ELOVL5 (elongation of very long chain fatty acid protein 5), a key enzyme involved in fatty acid elongation, was identified as a direct target of miR-30b-5p. Overexpression of miR-30b-5p or knockdown of Elovl5 inhibited the elongation of polyunsaturated fatty acids (PUFAs), leading to endothelial inflammation, which was rescued by PUFA supplementation. In vivo, overexpression of miR-30b-5p accelerated atherogenesis, whereas its inhibition ameliorated vascular lesions. miR-30b-5p levels in human serum-derived EVs positively correlated with the early-stage MASLD indices. Our findings identify the EV-derived miR-30b-5p/ELOVL5 axis as a novel mechanistic link between MASLD and CVD. miR-30b-5p may function as both a biomarker and a therapeutic target for early intervention of CVD among patients with MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAtherosclerosisHepatocytesFatty Acid ElongasesExtracellular VesiclesFatty LiverAcetyltransferasesHumansAnimalsMiceMaleEndothelial CellsGene Expression RegulationDisease Models, AnimalPalmitic AcidHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

cardiovascular diseaseendothelial dysfunctionextracellular vesiclemetabolic dysfunction-associated steatotic liver diseasepolyunsaturated fatty acid

Substanzen

MicroRNAsFatty Acid ElongasesMIRN30b microRNA, humanELOVL5 protein, humanAcetyltransferasesPalmitic Acid

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Institute of Biomedical Industry, College…
  • College of Pharmacy, Seoul National University, Seoul 08826, Korea.
  • Department of Biochemistry and Convergence Medical Science, Institute of Medical Science, College of Medicine, Gyeongsang National University, Jinju 52727, Korea.
  • Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

Förderung

  • National Research Foundation of Korea
  • Korea Health Industry Development Institute

Zitieren

APA

Rhee, M., Lee, J., Jung, C. W., Yang, J., Choi, W. G., You, Y. H., Park, H. S., Lee, E. Y., Lee, E. K., Kwon, S. W., Kim, Y. B., & Lee, S. H. (2026). Extracellular vesicles from steatotic hepatocytes promote endothelial dysfunction and atherogenesis via miR-30b-5p/ELOVL5 axis. Molecular Therapy, 34(9), 5382-5398. https://doi.org/10.1016/j.ymthe.2026.06.031

Vancouver

Rhee M, Lee J, Jung CW, Yang J, Choi WG, You YH, et al. Extracellular vesicles from steatotic hepatocytes promote endothelial dysfunction and atherogenesis via miR-30b-5p/ELOVL5 axis. Molecular Therapy. 2026;34(9):5382-5398. doi:10.1016/j.ymthe.2026.06.031

BibTeX
@article{Rhee2026,
  author = {Rhee, Marie and Lee, Joonyub and Jung, Cheol Woon and Yang, Jinsung and Choi, Won Gun and You, Young-Hye and Park, Heon-Seok and Lee, Eun Young and Lee, Eun Kyung and Kwon, Sung Won and Kim, Young-Bum and Lee, Seung-Hwan},
  title = {Extracellular vesicles from steatotic hepatocytes promote endothelial dysfunction and atherogenesis via miR-30b-5p/ELOVL5 axis},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {9},
  pages = {5382--5398},
  doi = {10.1016/j.ymthe.2026.06.031}
}
Kostenlos starten →